Procalcitonin-guided therapy in intensive care unit patients with severe sepsis and septic shock – a systematic review and meta-analysis
Critical Care2013Vol. 17(6), pp. R291–R291
Citations Over TimeTop 1% of 2013 papers
Abstract
Procalcitonin-guided therapy is a helpful approach to guide antibiotic therapy and surgical interventions without a beneficial effect on mortality. The major benefit of PCT-guided therapy consists of a shorter duration of antibiotic treatment compared to standard care. Trials are needed to investigate the effect of PCT-guided therapy on mortality, length of ICU and in-hospital stay in severe sepsis patients.
Related Papers
- → Prognosis scores on septic shock and severe sepsis in older people(2009)1 cited
- → Impact of the sepsis bundle strategy on the outcomes of the patients suffering from severe sepsis and septic shock(2010)
- → Faculty Opinions recommendation of Albumin replacement in patients with severe sepsis or septic shock.(2014)
- → Faculty Opinions recommendation of Soluble MD-2 activity in plasma from patients with severe sepsis and septic shock.(2004)
- → An update on recommendations for the treatment of severe sepsis and septic shock has been released(2008)